The approval includes usage for a range of age groups – from one year of age up to adulthood
The European Commission has approved BetaVia Complete to be placed on the market in the European Union with five-year exclusivity on sales of the product.
The product is an algae-sourced beta-glucan ingredient for year-round immune support, manufactured using a proprietary strain of algae, Euglena gracilis ATCC PTA-123017.
On December 2, 2020, following discussion and a favourable vote on September 21, from all member states at the Standing Committee on Plants, Animals, Food and Feed, the European Commission published the implementing regulation that authorises BetaVia Complete to be placed on the market in the European Union and grants the company five-year sales exclusivity in the European Union.
The approval includes usage for a range of age groups – from one year of age and up to adulthood – and allows for dried Euglena gracilis to be used as a novel food in food supplements, diet replacements for weight control and various general food categories.
The ingredient contains more than 50% beta 1,3 glucan, as well as proteins, fatty acids, vitamins, minerals and carotenoids to support the immune system, Kemin says.
These immune effects are reportedly supported by clinical and preclinical research on the respiratory and gastrointestinal tract.
“With consumers adopting a holistic approach to health and becoming more prone to make diet and lifestyles changes in order to improve immunity, we are thrilled to now have BetaVia Complete officially available in Europe,” said Filipa Quintela, Marketing Manager, Europe, Kemin Human Nutrition and Health.
“EFSA conducted an extremely rigorous evaluation of the safety data on BetaVia Complete, and this tremendous achievement demonstrates the strength of the Novel Food dossier Kemin Human Nutrition and Health submitted to the European Commission,” said Pedro Vieira, VP, Europe and Latin America, Kemin Human Nutrition and Health. “We are extremely excited to see the Commission Implementing Regulation published, which finally allows us to offer BetaVia Complete to the European market, one of the key markets for Kemin Human Nutrition and Health.”